World's Best Scientists 2026 revealed!
Award Badge
Medicine
Israel
2026

D-Index & Metrics

Medicine

D-Index
144
Citations
91325
World Ranking
1428
National Ranking
2

Research.com Recognitions

  • 2026 - Research.com Medicine in Israel Leader Award
  • 2025 - Research.com Medicine in Israel Leader Award
  • 2023 - Research.com Medicine in Israel Leader Award
  • 2022 - Research.com Medicine in Israel Leader Award

Overview

Arnon Nagler is affiliated with Sheba Medical Center in Israel and has an extensive publication record in the field of medicine, with a particular focus on hematology. Their research spans multiple subfields including oncology, public health, environmental and occupational health, immunology, and molecular biology.

The scientist's main research topics include:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • CAR-T Cell Therapy Research
  • Polyomavirus and Related Diseases
  • Immune Cell Function and Interaction
  • Chronic Myeloid Leukemia Treatments

Arnon Nagler has published numerous papers in prominent scientific journals. Some recent notable publications are:

  • "Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation," 2020, The Lancet Haematology
  • "Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)," 2021, Annals of Oncology
  • "Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations," 2023, Blood
  • "Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients," 2020, Bone Marrow Transplantation
  • "Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy," 2021, Transplantation and Cellular Therapy

Frequent co-authors collaborating with Arnon Nagler include:

  • Mohamad Mohty
  • Myriam Labopin
  • Fabio Ciceri
  • Didier Blaise
  • Bipin N. Savani

Arnon Nagler's work appears regularly in several scientific venues such as:

  • Bone Marrow Transplantation
  • Blood
  • Biology of Blood and Marrow Transplantation
  • Transplantation and Cellular Therapy
  • Blood Advances

The scope of Arnon Nagler's research covers both clinical and translational aspects related to stem cell transplantation and hematological malignancies, contributing significantly to consensus guidelines and best practice recommendations in related therapies and management.

Best Publications

  • Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

    Shimon Slavin;Arnon Nagler;Ella Naparstek;Yossi Kapelushnik

  • Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4

    Amnon Peled;Isabelle Petit;Orit Kollet;Michal Magid

  • G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4

    Isabelle Petit;Martine Szyper-Kravitz;Arnon Nagler;Meir Lahav

  • The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.

    Amnon Peled;Orit Kollet;Tanya Ponomaryov;Isabelle Petit

  • Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression

    Robert Z. Orlowski;Arnon Nagler;Pieter Sonneveld;Joan Bladé

  • Autologous transplantation and maintenance therapy in multiple myeloma

    Antonio Palumbo;Federica Cavallo;Francesco Di Raimondo

  • HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver.

    Orit Kollet;Shoham Shivtiel;Yuan Qing Chen;Jenny Suriawinata

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function

    Tanya Ponomaryov;Amnon Peled;Isabelle Petit;Russell S. Taichman

  • Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

    Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser

  • Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).

    M. Aoudjhane;M. Labopin;N. C. Gorin;A. Shimoni

  • CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow.

    Abraham Avigdor;Polina Goichberg;Shoham Shivtiel;Ayelet Dar

  • Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

    M. Mohty;F. Malard;M. Abecassis;E. Aerts

  • Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

    Philippe Armand;Arnon Nagler;Edie A. Weller;Steven M. Devine

  • Antilymphocyte globulin for prevention of chronic graft-versus-host disease

    Nicolaus Kröger;Carlos Solano;Christine Wolschke;Giuseppe Bandini

  • Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.

    Shimon Slavin;Elizabeth Naparstek;Arnon Nagler;Aliza Ackerstein

  • Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

    Jakob Passweg;H. Baldomero;P. Bader;Chiara Bonini

  • Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

    Carlo Gambacorti-Passerini;Laura Antolini;Franois Xavier Mahon;Francois Guilhot

  • CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.

    Sigal Tavor;Isabelle Petit;Svetlana Porozov;Abraham Avigdor;Abraham Avigdor

  • Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    Nicolaus Kröger;Ernst Holler;Guido Kobbe;Martin Bornhäuser

Frequent Co-Authors

Myriam Labopin
Myriam Labopin Université Paris Cité
Gérard Socié
Gérard Socié Université Paris Cité
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Nicolaus Kröger
Nicolaus Kröger Universität Hamburg
Jürgen Finke
Jürgen Finke University of Freiburg
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine isn’t limited to becoming a physician. There are a variety of online degrees and career pathways available for those interested in healthcare. With flexible schedules and lower tuition rates, online programs are an appealing option for many students.

Students considering roles in healthcare administration may find HIM programs particularly valuable. These degrees focus on the management of health information systems, an area seeing rapid growth due to increased digitization.

For those drawn to the financial or administrative side of healthcare, exploring medical billing and coding cost can offer insight into affordable courses that lead directly to in-demand certifications.

Nursing remains one of the most respected and stable healthcare careers. Prospective nurses can choose from a variety of nursing degree online options, or advance their skills through affordable NP programs for enhanced autonomy and responsibilities.

Whether your interests lie in clinical practice, administration, or healthcare management, exploring these related online degrees can open the door to rewarding career pathways in the U.S. medical field.

Best Scientists Citing Arnon Nagler

Trending Scientists

Recently Published Articles